Event Title

P-44 Synthesis of Benzothiazoles to Test for Anti-cancer Properties and Prevent Invasion of Glioblastoma

Location

Buller Hall Lobby

Start Date

3-8-2019 2:30 PM

Description

Glioblastoma is a malignant brain cancer responsible for taking many lives. With a high fatality rate and a post-diagnosis survival rate of about 15 months, Glioblastoma needs an urgent solution. The current treatments for Glioblastoma are surgical and do not completely remove all the cancerous cells. This research investigates whether introducing novel drugs (Benzothiazoles) as treatment will decrease the chances of reoccurrence and increase survival rate of Glioblastoma. Currently, I am synthesizing Benzothiazoles and running IR and NMR tests. After synthesizing the Benzothiazoles, I will proceed to test their effects on cell viability, determine the lethal dose (LD50) of the cells, and pursue other objectives of this research.

Acknowledgments

Supervising Professor: Denise Smith

This document is currently not available here.

Share

COinS
 
Mar 8th, 2:30 PM

P-44 Synthesis of Benzothiazoles to Test for Anti-cancer Properties and Prevent Invasion of Glioblastoma

Buller Hall Lobby

Glioblastoma is a malignant brain cancer responsible for taking many lives. With a high fatality rate and a post-diagnosis survival rate of about 15 months, Glioblastoma needs an urgent solution. The current treatments for Glioblastoma are surgical and do not completely remove all the cancerous cells. This research investigates whether introducing novel drugs (Benzothiazoles) as treatment will decrease the chances of reoccurrence and increase survival rate of Glioblastoma. Currently, I am synthesizing Benzothiazoles and running IR and NMR tests. After synthesizing the Benzothiazoles, I will proceed to test their effects on cell viability, determine the lethal dose (LD50) of the cells, and pursue other objectives of this research.